Severe cholestatic hepatitis in a patient taking acitretin [15]

American Journal of Gastroenterology

Volumn 97, Issue 3, 2002, Pages 775-777

  Kreiss, Christianna ^a   Amin, Shirish ^a   Nalesnik, Michael A ^a   Chopra, Kapil ^a   Obaid Shakil, A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 ANTITRYPSIN; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CERULOPLASMIN; DRUG METABOLITE; ETRETIN; ETRETINATE; MITOCHONDRION ANTIBODY; PREDNISONE; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; CASE REPORT; CHOLESTATIC HEPATITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; LETTER; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; PRIORITY JOURNAL; PSORIASIS;

EID: 0036127912     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04143-0     Document Type: Letter

References (16)

1. Acitretin in psoriasis: An overview of adverse effects
2. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis
3. Effects of acitretin on the liver
4. Atteinte hépatique aiguë au cours de la prise d'acitrétine
5. Efficacy and skeletal side effects of two years' acitretin treatment
6. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis
7. Long-term effects of etretinate on the liver in psoriasis
8. Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin)
9. A 12-month treatment of severe proriasis with acitretin: Results of a Canadian open multicenter study
10. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis
11. Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients
12. Cholestatic jaundice, an unusual side effect of etretinate
13. Hepatocanalicular injury associated with vitamin A derivative etretinate
14. Cholestatic hepatitis occurring shortly after etretinate therapy
15. Conversion of acitretin to etretinate in proriatic patients is influenced by ethanol
16. Acitretin biotransformation into etretinate: Role of ethanol on in vitro hepatic metabolism